Skip to content

Study · In vitro (cells) · 2016

1 result

Binding of Synthetic LKEKK Peptide to Human T-Lymphocytes.

Navolotskaya EV, Zinchenko DV, Zolotarev YA, Kolobov AA, Lipkin VM

Biochemistry. Biokhimiia1 Aug 2016Cited by 3 (Europe PMC)

PMID27677554 (opens in a new tab)DOI10.1134/s0006297916080071 (opens in a new tab)PepBankPUB-27677554
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Activity measurement

    Thymosin alpha‑1 inhibited binding of labelled LKEKK to donor blood T-lymphocytes with a Ki of 2.0 nM.

    In plain wordsIn cells, thymosin alpha‑1 blocked the binding of the labelled LKEKK peptide to human T cells.

    Peptide
    Thymosin alpha-1
    Outcome
    Not applicableInhibition of [3H]LKEKK binding by thymosin alpha 1
    Study

    humann: not reported in source

    Donor blood T-lymphocytes
    Outcome group
    Receptor activity and mechanism · Immune and inflammation
    Studied dose
    Dose not stated

    Measurements

    Ki
    2 nM
    inhibition of [3H]LKEKK binding to T-lymphocytes

    Source sentences

    Summary
    The binding was inhibited by thymosin-α1, interferon-α2, and cholera toxin B subunit (Ki = 2.0 ± 0.3, 2.2 ± 0.2, and 3.6 ± 0.3 nM, respectively).
    1 context sentence
    Summary · context
    The [3H]LKEKK bound with high affinity (Kd = 3.7 ± 0.3 nM) to donor blood T-lymphocytes.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.